Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070642
Status:
COMPLETED
Last Update Posted:
2009-02-10
First Post:
2003-10-06
Brief Title:
CPG 7909 Injection in Melanoma
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
ProMune CPG 7909 Injection With or Without Chemotherapy for the Treatment of Stage III bc or IV Melanoma A Randomized Multi-Center Open Label Parallel Group Active-Controlled Phase IIIII Study
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety tolerability and effects of CPG 7909 the study drug when given with chemotherapy to patients with melanoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CO23 A8501023 | None | None | None |